Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Witkin, Jeffrey M.
and
Eiler II, William J.A.
2006.
Antagonism of metabotropic glutamate group II receptors in the potential treatment of neurological and neuropsychiatric disorders.
Drug Development Research,
Vol. 67,
Issue. 9,
p.
757.
Martin, P.
2006.
L’association antidépresseur et anxiolytique aujourd’hui: bilan et prospective.
L'Encéphale,
Vol. 32,
Issue. 5,
p.
753.
2006.
Dietary-Free Glutamate: Implications for Research on Fear-Overconsolidation and PTSD.
CNS Spectrums,
Vol. 11,
Issue. 1,
p.
14.
Bosch, Oliver J.
Sartori, Simone B.
Singewald, Nicolas
and
Neumann, Inga D.
2007.
Extracellular amino acid levels in the paraventricular nucleus and the central amygdala in high- and low-anxiety dams rats during maternal aggression: Regulation by oxytocin.
Stress,
Vol. 10,
Issue. 3,
p.
261.
Augustin, Hrvoje
Grosjean, Yael
Chen, Kaiyun
Sheng, Qi
and
Featherstone, David E.
2007.
Nonvesicular Release of Glutamate by Glial xCT Transporters Suppresses Glutamate Receptor ClusteringIn Vivo.
The Journal of Neuroscience,
Vol. 27,
Issue. 1,
p.
111.
Walf, Alicia A
and
Frye, Cheryl A
2007.
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents.
Nature Protocols,
Vol. 2,
Issue. 2,
p.
322.
Kapfhammer, H. -P.
2008.
Psychiatrie und Psychotherapie.
p.
1569.
Pollack, Mark H.
Jensen, J. Eric
Simon, Naomi M.
Kaufman, Rebecca E.
and
Renshaw, Perry F.
2008.
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 32,
Issue. 3,
p.
739.
Cryan, John F.
and
Dev, Kumlesh K.
2008.
Handbook of Anxiety and Fear.
Vol. 17,
Issue. ,
p.
269.
Helsley, James D.
2008.
Anxiety Disorders.
p.
183.
Zdanys, Kristina
and
Tampi, Rajesh R.
2008.
A systematic review of off-label uses of memantine for psychiatric disorders.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 32,
Issue. 6,
p.
1362.
Sanacora, Gerard
Zarate, Carlos A.
Krystal, John H.
and
Manji, Husseini K.
2008.
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.
Nature Reviews Drug Discovery,
Vol. 7,
Issue. 5,
p.
426.
Kapfhammer, H. -P.
2008.
Psychiatrie und Psychotherapie.
p.
1661.
Satow, Akio
Maehara, Shunsuke
Ise, Satoko
Hikichi, Hirohiko
Fukushima, Miyuki
Suzuki, Gentaroh
Kimura, Toshifumi
Tanaka, Takeshi
Ito, Satoru
Kawamoto, Hiroshi
and
Ohta, Hisashi
2008.
Pharmacological Effects of the Metabotropic Glutamate Receptor 1 Antagonist Compared with Those of the Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 2/3 Agonist in Rodents: Detailed Investigations with a Selective Allosteric Metabotropic Glutamate Receptor 1 Antagonist, FTIDC [4-[1-(2-Fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
Journal of Pharmacology and Experimental Therapeutics,
Vol. 326,
Issue. 2,
p.
577.
Machado-Vieira, Rodrigo
Salvadore, Giacomo
DiazGranados, Nancy
and
Zarate, Carlos A.
2009.
Ketamine and the next generation of antidepressants with a rapid onset of action.
Pharmacology & Therapeutics,
Vol. 123,
Issue. 2,
p.
143.
Gao, Keming
Sheehan, David V
and
Calabrese, Joseph R
2009.
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.
Expert Review of Neurotherapeutics,
Vol. 9,
Issue. 8,
p.
1147.
Marks, David M.
Patkar, Ashwin A.
Masand, Prakash S.
and
Pae, Chi-Un
2009.
Does Pregabalin Have Neuropsychotropic Effects?: A Short Perspective.
Psychiatry Investigation,
Vol. 6,
Issue. 2,
p.
55.
Martin, Elizabeth I.
Ressler, Kerry J.
Binder, Elisabeth
and
Nemeroff, Charles B.
2009.
The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology.
Psychiatric Clinics of North America,
Vol. 32,
Issue. 3,
p.
549.
Wieronska, Joanna M.
Nowak, Gabriel
and
Pilc, Andrzej
2010.
Glutamate-based Therapies for Psychiatric Disorders.
p.
157.
Delawary, Mina
Tezuka, Tohru
Kiyama, Yuji
Yokoyama, Kazumasa
Inoue, Takeshi
Hattori, Satoko
Hashimoto, Ryota
Umemori, Hisashi
Manabe, Toshiya
Yamamoto, Tadashi
and
Nakazawa, Takanobu
2010.
NMDAR2B tyrosine phosphorylation regulates anxiety-like behavior and CRF expression in the amygdala.
Molecular Brain,
Vol. 3,
Issue. 1,